Carbonic Anhydrase Inhibitors

02/14/2002 - "Carbonic anhydrase inhibitors are effective in lowering intraocular pressure, the primary indication of glaucoma. "
08/01/2015 - "To evaluate the effectiveness of carbonic anhydrase inhibitors as the fourth drug regarding intraocular pressure (IOP) control in patients with primary glaucomas. "
08/01/2015 - "Carbonic anhydrase inhibitors as fourth drug in primary glaucomas: Is it worth it?"
03/01/2015 - "Carbonic anhydrase inhibitors (CAIs) are some of the principal drugs used in the management of canine and feline glaucoma. "
03/01/2015 - "A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats."

01/01/2012 - "As new carbonic anhydrase inhibitors are being evaluated, testing additional tumors for CAIX may lead to novel treatment options."
04/02/2012 - "Enhanced receptor selectivity: carbonic anhydrase inhibitors are relevant for both cancer diagnosis and therapy. "
01/01/2007 - "Carbonic anhydrase inhibitors and the management of cancer."
04/01/2006 - "Carbonic anhydrase inhibitors: transepithelial transport of thioureido sulfonamide inhibitors of the cancer-associated isozyme IX is dependent on efflux transporters."
02/23/2004 - "Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX."

01/15/1989 - "Intraocular pressure effects of carbonic anhydrase inhibitors in primary open-angle glaucoma."
12/01/2009 - "Nitric oxide-donating carbonic anhydrase inhibitors for the treatment of open-angle glaucoma."
01/01/2006 - "We studied 4 groups of 10 subjects each: a control group, and 3 primary open angle glaucoma (POAG) groups, treated with topical beta-blockers, (10 patients), carbonic anhydrase inhibitors (CAI), and prostaglandin analogs (PG), respectively. "
01/01/2005 - "There was no evidence to determine the effectiveness of contemporary medication (prostaglandin analogues, alpha2-agonists and topical carbonic anhydrase inhibitors) compared to surgery in severe OAG, and in people of black African ethnic origin who have a greater risk of more severe open angle glaucoma. "
03/01/1991 - "Topical carbonic anhydrase inhibitors MK-507 and sezolamide hydrochloride (previously known as MK-417) were compared in a double-masked, randomized, placebo-controlled study in 82 patients with bilateral primary open-angle glaucoma or ocular hypertension. "

01/01/1999 - "Medical treatment of cystoid macular edema (CME) with carbonic anhydrase inhibitors has been known for over a decade. "
01/01/1999 - "The role of carbonic anhydrase inhibitors in the management of macular edema."
03/01/2015 - "To determine the efficacy and prognostic factors associated with carbonic anhydrase inhibitors (CAI) in the treatment of cystoid macular edema (CME) in retinitis pigmentosa (RP). "
03/01/2015 - "Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa."
01/01/2013 - "Oral carbonic anhydrase inhibitors have been the treatment of choice for managing cystoid macular edema (CMO) in retinitis pigmentosa. "

03/01/2015 - "To determine the efficacy and prognostic factors associated with carbonic anhydrase inhibitors (CAI) in the treatment of cystoid macular edema (CME) in retinitis pigmentosa (RP). "
03/01/2015 - "Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa."
01/01/2013 - "Oral carbonic anhydrase inhibitors have been the treatment of choice for managing cystoid macular edema (CMO) in retinitis pigmentosa. "
02/01/2011 - "Retrospective chart review was conducted on all patients with retinitis pigmentosa or X-linked retinoschisis who were either currently on treatment or had been treated with carbonic anhydrase inhibitors for cystic macular lesions. "
02/01/2011 - "The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis."